Moneycontrol PRO
ipca laboratories
Jump to
391 Results Found
  • MSCI adds four cos to India index; removes Oil India, DLF Nov 13, 2015 10:03 PM IST

    MSCI adds four cos to India index; removes Oil India, DLF

    Ashok Leyland, Cadila Healthcare, Maruti Suzuki India and Tata Motors have been added to the index. Shares of Ashok Leyland were down 0.22 percent, Cadila lost 1.09 percent, Maruti dipped by 2.59 percent.

  • Samvat 2072 - Opportunities amidst challenges: Reliance Sec Nov 13, 2015 11:59 AM IST

    Samvat 2072 - Opportunities amidst challenges: Reliance Sec

    Reliance Securities, has recommend Hexaware, Persistent, HDFC Bank, IPCA Lab and Shriram Transport as Top Stocks Picks for Diwali Samvat 2072

  • Stocks in news: Indiabulls Hsg, SpiceJet, Coal India, CESC Nov 13, 2015 08:23 AM IST

    Stocks in news: Indiabulls Hsg, SpiceJet, Coal India, CESC

    Tata Steel | SBI | Indiabulls Housing Finance | SpiceJet | Coal India | Wockhardt | Kotak Mahindra Bank | ICICI Bank | Axis Bank | IndusInd Bank | Yes Bank | NMDC | Prabhat Dairy | Valecha Engineering | Tilaknagar Industries | Shree Renuka Sugars and Dr Reddy's Laboratories are stocks, which are in the news today.

  • Reduce Ipca Laboratories; target Rs 565: Edelweiss Nov 06, 2015 04:56 PM IST

    Reduce Ipca Laboratories; target Rs 565: Edelweiss

    Edelweiss has recommended a reduce rating on Ipca Laboratories with a target price of Rs 565, in its November 04, 2015 research report.

  • Hold Ipca Laboratories;target of Rs 779:Sharekhan Nov 05, 2015 07:45 PM IST

    Hold Ipca Laboratories;target of Rs 779:Sharekhan

    Sharekhan has recommended hold rating on Ipca Laboratories with a target price of Rs 779 in its research report dated November 4, 2015.

  • Accumulate IPCA Labs on correction: Mayuresh Joshi Nov 02, 2015 04:51 PM IST

    Accumulate IPCA Labs on correction: Mayuresh Joshi

    Mayuresh Joshi of Angel Broking recommends accumulating IPCA Labs on correction.

  • Ipca Labs Q2 net nosedives 81% to Rs 12 cr Oct 30, 2015 06:49 PM IST

    Ipca Labs Q2 net nosedives 81% to Rs 12 cr

    Ipca Laboratories manufactures over 350 formulations and 80 APIs for various therapeutic segments.

  • Buy Cipla, Take Solutions, Ipca Laboratories: Kunal Bothra Oct 30, 2015 03:08 PM IST

    Buy Cipla, Take Solutions, Ipca Laboratories: Kunal Bothra

    Kunal Bothra, Head of Advisory at LKP recommends buying Cipla, Take Solutions and Ipca Laboratories.

  • Here are trading ideas from Kunal Bothra and Amit Harchekar Oct 30, 2015 02:49 PM IST

    Here are trading ideas from Kunal Bothra and Amit Harchekar

    Watch the interview of Kunal Bothra as Head of Advisory at LKP and Amit Harchekar of A PLUS Analytics with Mangalam Maloo & Ekta Batra on CNBC-TV18, in which they shared theirs readings and outlook on market and specific stocks.

  • Cadila Healthcare Q2 profit seen up 31% on US formulations Oct 21, 2015 11:06 AM IST

    Cadila Healthcare Q2 profit seen up 31% on US formulations

    Opinion is mixed on the amount of growth in US markets as some analysts expect 20-25 percent growth due to arthritis drug HCQs price hikes (Hydroxychloroquine) while others expect constant currency growth of around 13-15 percent due to erosion in other products.

  • Buy Ipca Labs, target Rs 800-810: Rahul Mohindar Oct 19, 2015 04:30 PM IST

    Buy Ipca Labs, target Rs 800-810: Rahul Mohindar

    Rahul Mohindar of viratechindia.com recommends buying Ipca Labs for a target of Rs 800-810.

  • Buy CESC, Ipca Labs, Glenmark Pharma, Rel Comm: Rajat Bose Oct 16, 2015 02:41 PM IST

    Buy CESC, Ipca Labs, Glenmark Pharma, Rel Comm: Rajat Bose

    Rajat Bose of rajatkbose.com advises buying Glenmark Pharma, Ipca Labs and CESC.

  • Buy pharma stocks on corrections: Prakash Diwan Oct 08, 2015 04:34 PM IST

    Buy pharma stocks on corrections: Prakash Diwan

    Prakash Diwan of Altamount Capital Management is of the view that one may buy pharma stocks on corrections.

  • Buy pharma stocks on corrections: Prakash Diwan Oct 08, 2015 04:15 PM IST

    Buy pharma stocks on corrections: Prakash Diwan

    Prakash Diwan of Altamount Capital Management is of the view that one may buy pharma stocks on corrections.

  • Glenmark Pharma top pick, says Prakash Diwan Sep 07, 2015 11:05 AM IST

    Glenmark Pharma top pick, says Prakash Diwan

    Prakash Diwan of Altamount Capital Management is of the view that Glenmark Pharma is one of the top picks.

  • India an ‘oasis‘ in volatile environment: Edelweiss Sec Sep 03, 2015 03:26 PM IST

    India an ‘oasis‘ in volatile environment: Edelweiss Sec

    Going forward from a 12-18 month perspective Nischal Maheshwari, Head of Institutional Equities at Edelweiss Securities expects a 12-15 percent upside for the market.

  • Bull's Eye: Sell Bharat Forge, JSW Steel, buy Voltas Sep 01, 2015 07:59 AM IST

    Bull's Eye: Sell Bharat Forge, JSW Steel, buy Voltas

    Jay Thakkar of Sharekhan advises buying Dr Reddy's Laboratories with a target of Rs 4390.

  • Bull's Eye: Sell UPL, Ceat, LIC Housing, buy Delta Corp Aug 31, 2015 07:55 AM IST

    Bull's Eye: Sell UPL, Ceat, LIC Housing, buy Delta Corp

    Vishal Malkan of malkansview.com is of the view that one may sell UPL with a target of Rs 500.

  • Power punch: 15 midcaps that outperformed market fall Aug 28, 2015 09:28 AM IST

    Power punch: 15 midcaps that outperformed market fall

    Here are the 15 midcaps which gain 4-25 percent in the last one month (July 27-August 27).

  • Check Out: Super Six stocks for August 21 Aug 21, 2015 08:54 AM IST

    Check Out: Super Six stocks for August 21

    Jay Thakkar of ShareKhan suggests selling Axis Bank with a target of Rs 490.

  • Like Divis Laboratories, Torrent Pharma: Anmol Ganjoo Aug 20, 2015 04:17 PM IST

    Like Divis Laboratories, Torrent Pharma: Anmol Ganjoo

    Anmol Ganjoo of JM Financial likes Divis Laboratories and Torrent Pharma from the pharma space.

  • Glenmark Pharma top pick, like Ipca Lab: Sudip Bandopadhyay Aug 18, 2015 04:46 PM IST

    Glenmark Pharma top pick, like Ipca Lab: Sudip Bandopadhyay

    Sudip Bandopadhyay of Destimoney Securities is of the view that Glenmark Pharma is the top pick and likes Ipca Labs and Indoco Remedies.

  • BNP ups Infosys target price, Barclays +ve on Coal India Aug 18, 2015 08:59 AM IST

    BNP ups Infosys target price, Barclays +ve on Coal India

    Brokerage firms are positive on Infosys and Coal India on back of good June quarter earnings and a positive outlook for the entire year.

  • 6 stocks likely to see lot of action today Aug 17, 2015 08:52 AM IST

    6 stocks likely to see lot of action today

    Jay Thakkar of ShareKhan is of the view that one may buy Ipca Laboratories with a target of Rs 875.

  • Ipca Laboratories may move to Rs 800-805: Rahul Mohindar Aug 12, 2015 02:55 PM IST

    Ipca Laboratories may move to Rs 800-805: Rahul Mohindar

    Rahul Mohindar of viratechindia.com is of the view that Ipca Laboratories may move to Rs 800-805.

Sections
ISO 27001 - BSI Assurance Mark